alfuzosin hydrochloride

Generic: alfuzosin hydrochloride

Labeler: northwind health company, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name alfuzosin hydrochloride
Generic Name alfuzosin hydrochloride
Labeler northwind health company, llc
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

alfuzosin hydrochloride 10 mg/1

Manufacturer
Northwind Health Company, LLC

Identifiers & Regulatory

Product NDC 51655-967
Product ID 51655-967_4974b10e-b8f0-5aa8-e063-6294a90acd65
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA203192
Listing Expiration 2027-12-31
Marketing Start 2023-06-29

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 51655967
Hyphenated Format 51655-967

Supplemental Identifiers

RxCUI
861132
UNII
75046A1XTN

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name alfuzosin hydrochloride (source: ndc)
Generic Name alfuzosin hydrochloride (source: ndc)
Application Number ANDA203192 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 10 mg/1
source: ndc
Packaging
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-967-52)
source: ndc

Packages (1)

Ingredients (1)

alfuzosin hydrochloride (10 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4974b10e-b8f0-5aa8-e063-6294a90acd65", "openfda": {"unii": ["75046A1XTN"], "rxcui": ["861132"], "spl_set_id": ["ffbd22eb-9df5-e0ad-e053-6294a90a7d4e"], "manufacturer_name": ["Northwind Health Company, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-967-52)", "package_ndc": "51655-967-52", "marketing_start_date": "20230629"}], "brand_name": "Alfuzosin hydrochloride", "product_id": "51655-967_4974b10e-b8f0-5aa8-e063-6294a90acd65", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "51655-967", "generic_name": "Alfuzosin hydrochloride", "labeler_name": "Northwind Health Company, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Alfuzosin hydrochloride", "active_ingredients": [{"name": "ALFUZOSIN HYDROCHLORIDE", "strength": "10 mg/1"}], "application_number": "ANDA203192", "marketing_category": "ANDA", "marketing_start_date": "20230629", "listing_expiration_date": "20271231"}